Eur Rev Med Pharmacol Sci 2022; 26 (16): 5633-5634
DOI: 10.26355/eurrev_202208_29495

Reply Letter to Recommended revisions to the article “Prehabilitation and heart failure”

S. Giovannini, L. Castelli, C. Loreti, F. Brau, L. Biscotti, R. Bernabei

Department of Geriatrics and Orthopaedics, Università Cattolica del Sacro Cuore, Rome, Italy. silvia.giovannini@unicatt.it

Free PDF Download

To cite this article

S. Giovannini, L. Castelli, C. Loreti, F. Brau, L. Biscotti, R. Bernabei
Reply Letter to Recommended revisions to the article “Prehabilitation and heart failure”

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 16
Pages: 5633-5634
DOI: 10.26355/eurrev_202208_29495

Keywords Related articles:

  1. Recommended revisions to the article “Prehabilitation and heart failure”
  2. Prehabilitation and heart failure: main outcomes in the COVID-19 era
  3. Prehabilitation and heart failure: perspective in primary outcomes, a randomized controlled trial
  4. Reply Letter – Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?
  5. Impact of QRS morphology on heart rate turbulence and heart rate variability after cardiac resynchronization therapy in patients with heart failure